J J to Buy Guidant for \$23.9 Billion  NEW YORK (Reuters) - Johnson   Johnson will buy Guidant  Corp. for \$23.9 billion in cash and stock, giving the  health-care products maker a foothold in the fast-growing  market for implantable devices that regulate heartbeats, J J  said on Wednesday.